- Home
- BTAI vs HFBL Comparison
BTAI vs HFBL Comparison
Compare BTAI & HFBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTAI
- HFBL
- Stock Information
- Founded
- BTAI 2017
- HFBL 1924
- Country
- BTAI United States
- HFBL United States
- Employees
- BTAI 37
- HFBL N/A
- Industry
- BTAI Biotechnology: Pharmaceutical Preparations
- HFBL Savings Institutions
- Sector
- BTAI Health Care
- HFBL Finance
- Exchange
- BTAI Nasdaq
- HFBL Nasdaq
- Market Cap
- BTAI 41.8M
- HFBL 41.6M
- IPO Year
- BTAI 2018
- HFBL N/A
- Fundamental
- Price
- BTAI $2.12
- HFBL $15.51
- Analyst Decision
- BTAI Buy
- HFBL
- Analyst Count
- BTAI 5
- HFBL 0
- Target Price
- BTAI $32.80
- HFBL N/A
- AVG Volume (30 Days)
- BTAI 691.3K
- HFBL 2.5K
- Earning Date
- BTAI 11-12-2025
- HFBL 10-23-2025
- Dividend Yield
- BTAI N/A
- HFBL 3.42%
- EPS Growth
- BTAI N/A
- HFBL 35.20
- EPS
- BTAI N/A
- HFBL 1.47
- Revenue
- BTAI $752,000.00
- HFBL $21,720,000.00
- Revenue This Year
- BTAI N/A
- HFBL N/A
- Revenue Next Year
- BTAI $544.99
- HFBL N/A
- P/E Ratio
- BTAI N/A
- HFBL $10.42
- Revenue Growth
- BTAI N/A
- HFBL 10.10
- 52 Week Low
- BTAI $1.17
- HFBL $12.28
- 52 Week High
- BTAI $9.26
- HFBL $16.95
- Technical
- Relative Strength Index (RSI)
- BTAI 54.12
- HFBL 54.03
- Support Level
- BTAI $1.72
- HFBL $15.25
- Resistance Level
- BTAI $2.09
- HFBL $15.63
- Average True Range (ATR)
- BTAI 0.18
- HFBL 0.25
- MACD
- BTAI 0.06
- HFBL -0.07
- Stochastic Oscillator
- BTAI 98.36
- HFBL 41.29
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About HFBL Home Federal Bancorp Inc. of Louisiana
Home Federal Bancorp Inc of louisiana operates as a bank holding company. It is a federally chartered stock savings bank, which provides financial services to individuals, corporate entities, and other organizations. Its core activities consist of attracting deposits from the general public and using those funds to originate loans to the residential, commercial and multi-family segments. The company also invests securities held-to-maturity and securities available for sale.